PL405241A1 - Micela polimerowa, sposób jej wytwarzania i zastosowanie - Google Patents

Micela polimerowa, sposób jej wytwarzania i zastosowanie

Info

Publication number
PL405241A1
PL405241A1 PL405241A PL40524113A PL405241A1 PL 405241 A1 PL405241 A1 PL 405241A1 PL 405241 A PL405241 A PL 405241A PL 40524113 A PL40524113 A PL 40524113A PL 405241 A1 PL405241 A1 PL 405241A1
Authority
PL
Poland
Prior art keywords
application
polymer micelle
producing
type
ethylene oxide
Prior art date
Application number
PL405241A
Other languages
English (en)
Inventor
Renata Frąckowiak
Urszula Posadowska
Kazimiera Anna Wilk
Andrzej Gamian
Original Assignee
Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Odpowiedzialnością filed Critical Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Odpowiedzialnością
Priority to PL405241A priority Critical patent/PL405241A1/pl
Priority to PCT/PL2014/050046 priority patent/WO2015034381A1/en
Priority to PL14762112T priority patent/PL3041510T3/pl
Priority to EP14762112.2A priority patent/EP3041510B1/en
Publication of PL405241A1 publication Critical patent/PL405241A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Przedmiotem wynalazku są nanonośniki typu micel polimerowych na bazie kopolimerów blokowych z wykorzystaniem metody hydratowania cienkiego filmu z kopolimeru blokowego: poli(tlenek etylenu-b-tlenek propylenu-b-tlenek etylenu) o wzorze ogólnym 1. Są one przeznaczone do stosowania w formulacjach farmaceutycznych jako nośniki substancji aktywnych typu fotouczulaczy stosowanych w terapii fotodynamicznej nowotworów, sposób ich wytwarzania oraz zastosowanie.
PL405241A 2013-09-04 2013-09-04 Micela polimerowa, sposób jej wytwarzania i zastosowanie PL405241A1 (pl)

Priority Applications (4)

Application Number Priority Date Filing Date Title
PL405241A PL405241A1 (pl) 2013-09-04 2013-09-04 Micela polimerowa, sposób jej wytwarzania i zastosowanie
PCT/PL2014/050046 WO2015034381A1 (en) 2013-09-04 2014-07-25 Polymer micelle containing a photosensitizer
PL14762112T PL3041510T3 (pl) 2013-09-04 2014-07-25 Micela polimerowa zawierająca fotouczulacz
EP14762112.2A EP3041510B1 (en) 2013-09-04 2014-07-25 Polymer micelle containing a photosensitizer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL405241A PL405241A1 (pl) 2013-09-04 2013-09-04 Micela polimerowa, sposób jej wytwarzania i zastosowanie

Publications (1)

Publication Number Publication Date
PL405241A1 true PL405241A1 (pl) 2015-03-16

Family

ID=51535495

Family Applications (2)

Application Number Title Priority Date Filing Date
PL405241A PL405241A1 (pl) 2013-09-04 2013-09-04 Micela polimerowa, sposób jej wytwarzania i zastosowanie
PL14762112T PL3041510T3 (pl) 2013-09-04 2014-07-25 Micela polimerowa zawierająca fotouczulacz

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL14762112T PL3041510T3 (pl) 2013-09-04 2014-07-25 Micela polimerowa zawierająca fotouczulacz

Country Status (3)

Country Link
EP (1) EP3041510B1 (pl)
PL (2) PL405241A1 (pl)
WO (1) WO2015034381A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112402625B (zh) * 2020-11-19 2022-12-09 健进制药有限公司 负载光敏剂的peg化肝素纳米胶束及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL110559B1 (en) 1977-11-28 1980-07-31 Composition for manufacturing sound insulating materialin the form of foil or plate
US6540981B2 (en) 1997-12-04 2003-04-01 Amersham Health As Light imaging contrast agents
US7356368B2 (en) 2004-07-21 2008-04-08 Boston Scientific Scimed, Inc. Light-activated anti-infective coatings and devices made thereof
MX2010012237A (es) 2008-05-13 2011-04-28 Univ Washington Micelas para el suministro intracelular de agentes terapeuticos.
KR20110091515A (ko) 2008-11-21 2011-08-11 주식회사 삼양사 내성암 치료용 고분자 미셀 조성물 및 그 제조방법
US20100131001A1 (en) 2008-11-24 2010-05-27 Medtronic Vascular, Inc. Targeted Drug Delivery for Aneurysm Treatment
US20100129432A1 (en) * 2008-11-25 2010-05-27 Taipei Medical University Microorganism-killing combination
EP2201935B1 (en) 2008-12-26 2020-07-08 Samyang Biopharmaceuticals Corporation Polymeric micelle composition containing a poorly soluble drug and preparation method of the same
US20100310660A1 (en) 2009-06-08 2010-12-09 Taipei Medical University Dry powder microparticles for pulmonary delivery
TW201113040A (en) * 2009-10-08 2011-04-16 Univ Kaohsiung Medical Folic acid-mediated magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications
EP2382966A1 (en) 2010-03-12 2011-11-02 DSM IP Assets B.V. Micelle compositions and process for the preparation thereof
WO2011113616A1 (en) 2010-03-19 2011-09-22 King Saud University A nanoparticle comprising a micelle formed by an amphiphilic block- copolymer and encapsulating a gadolinium complex
KR101213409B1 (ko) * 2010-07-14 2012-12-20 한국과학기술연구원 수계 분산 근적외 광열 유기 나노 입자 및 이의 제조 방법과 용도
US9295685B2 (en) * 2011-02-24 2016-03-29 Omeros Corporation Mixed micelles

Also Published As

Publication number Publication date
PL3041510T3 (pl) 2020-09-07
EP3041510B1 (en) 2020-01-08
WO2015034381A1 (en) 2015-03-12
EP3041510A1 (en) 2016-07-13

Similar Documents

Publication Publication Date Title
CY1122483T1 (el) Λυοφιλοποιημενες παρασκευες μελφαλανης φλουφεναμιδης
ECSP20020410A (es) Inhibidores de la ectonucleótido pirofosfatasa-fosfodiesterasa 1 (enpp-1) y usos de los mismos
CY1122329T1 (el) Anti-siglec-8 αντισωματα και μeθοδοι χρhσεως αυτων
CY1122730T1 (el) 1,2,4-τριαζολες ως διαμορφωτες πυρηνικης μεταφορας και χρησεις αυτων
CY1123414T1 (el) Antiμυκητιασικη τοπικη συνθεση και μεθοδοι θεραπειας
CY1121735T1 (el) 7-benzyλ-10-(2-meθyλobenzyλ)-2,6,7,8,9,10-eξaϋδpoϊmiδazo[1,2-α]πυριδο[4,3-d]πυριμιδιν-5(3η)-ονη για χρηση στην αγωγη του καρκινου
CY1120318T1 (el) Υποκατεστημενες βενζυλινδαζολες για χρηση ως αναστολεις κινασης bub1 στη θεραπευτικη αντιμετωπιση υπερπολλαπλασιαστικων ασθενειων
CY1123627T1 (el) Παραγωγα διυδροϊμιδαζοπυραζινονης χρησιμα στη θεραπευτικη αντιμετωπιση του καρκινου
CY1120619T1 (el) Χημικες οντοτητες
PH12014501368A1 (en) Oral care compositions
CL2013000018A1 (es) Compuestos derivados de indolizina , su procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento del cancer, entre otros.
UY34750A (es) ?compuestos para el tratamiento del hiv, composiciones,métodos de preparación, intermediarios y métodos terapéuticos?.
EA201491447A1 (ru) Ендиины, их конъюгаты и способы их получения и применения
WO2015160975A3 (en) Combination of a pi3k inhibitor with a bcl-2 inhibitor for use in the treatment of cancer
NZ735575A (en) Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
UY37253A (es) Compuestos conjugados de peg y carfilzomib
UA113541C2 (xx) Заміщені піролідин-2-карбоксаміди
CL2016003260A1 (es) Profármacos de gemcitabina
MX2018010032A (es) Formulaciones de antagonista de il-6 y sus usos.
BR112018011177A2 (pt) conjugados de citarabina para terapia de câncer
CY1111442T1 (el) Ενωσεις πιπεριδινης και χρησεις αυτων
BR112014027981A2 (pt) compostos do tipo fumagilol e métodos de produção e utilização dos mesmos
MX381617B (es) Conjugados de peptido-curcumina y formulaciones de los mismos.
BR112015020079A2 (pt) composições para cuidado oral
CY1114757T1 (el) Παραγωγα οξαζινης και η χρηση τους στη θεραπεια νευρολογικων διαταραχων